Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth I Ataga

Showing results (71-80 of 133) with videos related to

Pageof 14
Sort By:
Pharmacotherapy|October 27, 2006
Dose-escalation study of ICA-17043 in patients with sickle cell diseaseKenneth I Ataga, Eugene P Orringer, Lori Styles, et al.
American Journal of Hematology|March 23, 2026
The Longitudinal Effect of APOL1 Risk Alleles on Sickle Cell Anemia-Associated Kidney FunctionSara R Rashkin, Guolian Kang, Clifford M Takemoto, et al.
British Journal of Haematology|July 7, 2021
Hydroxyurea therapy decreases coagulation and endothelial activation in sickle cell disease: a Longitudinal StudyLaila Elsherif, Lara C Scott, David Wichlan, et al.
American Journal of Hematology|January 12, 2018
Effect of eptifibatide on inflammation during acute pain episodes in sickle cell diseaseJulia E Brittain, Ciprian Anea, Payal Desai, et al.
British Journal of Haematology|May 16, 2023
Urinary angiotensinogen is associated with albuminuria in adults with sickle cell anaemiaLaila Elsherif, Praghalathan Kanthakumar, Jeremiah Afolabi, et al.
Blood|December 31, 2002
Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesionPatrick C Hines, Qin Zen, Sharran N Burney, et al.
Haematologica|January 21, 2017
Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and EuropePoulami Maitra, Melissa Caughey, Laura Robinson, et al.
The American Journal of Medicine|October 27, 2004
Pulmonary hypertension in sickle cell diseaseKenneth I Ataga, Namita Sood, Guy De Gent, et al.
American Journal of Hematology|April 11, 2012
A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell diseaseAbdullah Kutlar, Kenneth I Ataga, Lillian McMahon, et al.
Blood Advances|February 11, 2021
Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemiaParul Rai, Vijaya M Joshi, Jason F Goldberg, et al.
Pageof 14

Showing results (71-80 of 133) with videos related to

Sort By:
Pageof 14
Pharmacotherapy|October 27, 2006
Dose-escalation study of ICA-17043 in patients with sickle cell diseaseKenneth I Ataga, Eugene P Orringer, Lori Styles, et al.
American Journal of Hematology|March 23, 2026
The Longitudinal Effect of APOL1 Risk Alleles on Sickle Cell Anemia-Associated Kidney FunctionSara R Rashkin, Guolian Kang, Clifford M Takemoto, et al.
British Journal of Haematology|July 7, 2021
Hydroxyurea therapy decreases coagulation and endothelial activation in sickle cell disease: a Longitudinal StudyLaila Elsherif, Lara C Scott, David Wichlan, et al.
American Journal of Hematology|January 12, 2018
Effect of eptifibatide on inflammation during acute pain episodes in sickle cell diseaseJulia E Brittain, Ciprian Anea, Payal Desai, et al.
British Journal of Haematology|May 16, 2023
Urinary angiotensinogen is associated with albuminuria in adults with sickle cell anaemiaLaila Elsherif, Praghalathan Kanthakumar, Jeremiah Afolabi, et al.
Blood|December 31, 2002
Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesionPatrick C Hines, Qin Zen, Sharran N Burney, et al.
Haematologica|January 21, 2017
Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and EuropePoulami Maitra, Melissa Caughey, Laura Robinson, et al.
The American Journal of Medicine|October 27, 2004
Pulmonary hypertension in sickle cell diseaseKenneth I Ataga, Namita Sood, Guy De Gent, et al.
American Journal of Hematology|April 11, 2012
A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell diseaseAbdullah Kutlar, Kenneth I Ataga, Lillian McMahon, et al.
Blood Advances|February 11, 2021
Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemiaParul Rai, Vijaya M Joshi, Jason F Goldberg, et al.
Pageof 14